Cargando…
Dietary advanced glycation end-products aggravate non-alcoholic fatty liver disease
AIM: To determine if manipulation of dietary advanced glycation end product (AGE), intake affects non-alcoholic fatty liver disease (NAFLD) progression and whether these effects are mediated via RAGE. METHODS: Male C57Bl6 mice were fed a high fat, high fructose, high cholesterol (HFHC) diet for 33 w...
Autores principales: | Leung, Christopher, Herath, Chandana B, Jia, Zhiyuan, Andrikopoulos, Sof, Brown, Bronwyn E, Davies, Michael J, Rivera, Leni R, Furness, John B, Forbes, Josephine M, Angus, Peter W |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5028816/ https://www.ncbi.nlm.nih.gov/pubmed/27672297 http://dx.doi.org/10.3748/wjg.v22.i35.8026 |
Ejemplares similares
-
Development and Progression of Non-Alcoholic Fatty Liver Disease: The Role of Advanced Glycation End Products
por: Fernando, Dinali H., et al.
Publicado: (2019) -
Angiotensin Converting Enzyme‐2 Therapy Improves Liver Fibrosis and Glycemic Control in Diabetic Mice With Fatty Liver
por: Rajapaksha, Indu G., et al.
Publicado: (2021) -
Advanced Glycation End-Products and Their Effects on Gut Health
por: Phuong-Nguyen, Kate, et al.
Publicado: (2023) -
Advanced Glycation End Products Are Direct Modulators of β-Cell Function
por: Coughlan, Melinda T., et al.
Publicado: (2011) -
Inhibition of Receptor for Advanced Glycation End Products as New Promising Strategy Treatment in Diabetic Retinopathy
por: Saleh, Irsan, et al.
Publicado: (2019)